Prorenoate potassium
Jump to navigation
Jump to search
| File:Prorenoate potassium.svg | |
| Clinical data | |
|---|---|
| Other names | SC-23992; 6α,7α-Dihydro-17-hydroxy-3-oxo-3'H-cyclopropa(6,7)-17α-pregna-4,6-diene-21-carboxylic acid monopotassium salt |
| Drug class | Antimineralocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C23H31KO4 |
| Molar mass | 410.595 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Prorenoate potassium (developmental code name SC-23992) is a synthetic steroidal antimineralocorticoid which was never marketed.[1][2]
See also
[edit | edit source]References
[edit | edit source]